Dermatologic and Ophthalmic Drugs Advisory Committee

Purpose

The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of dermatologic and ophthalmic disorders and makes appropriate recommendations to the Commissioner of Food and Drugs.

 

Committee Membership

The Committee shall consist of a core of 15 voting members including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of dermatology, ophthalmology, internal medicine, pathology, immunology, epidemiology or statistics, and other related professions. The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. In addition to the voting members, the Committee may include one non-voting member who is identified with industry interests.

 

Contact Information

LT Yvette Waples, Pharm.D., R.Ph., Designated Federal Official
Advisors and Consultants Staff
Center for Drug Evaluation and Research
Food and Drug Administration,
5630 Fishers Lane, HFD-21
Rockville, Maryland 20857
Phone: (301) 827-7001
Fax: (301) 827-6776
E-mail: Yvette.Waples@fda.hhs.gov

FDA Advisory Committee Information Line
1-800-741-8138
(301) 443-0572 (local number)
code: 3014512534
Please call the Information Line for up-to-date information on meetings.